Breast Cancer Day of Education 2026

Pharmacists are key members of the oncology care team involved in ensuring patients with breast cancer understand the intricate dosing, sequencing, and adverse effect profiles of specialized regimens. The 2026 Breast Cancer Day of Education provides oncology pharmacists with evidence-based updates on the use of targeted therapies including CDK4/6 inhibitors, PARP inhibitors, and HER2-targeted agents. Join PTCE for a full day of expert-led, case-based discussions designed to support understanding of mutational testing, managing challenging adverse effects, and driving patient adherence in both early-stage and metastatic disease.